Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Cancer Cell. 2014 Aug 11;26(2):222-34. doi: 10.1016/j.ccr.2014.06.026.
Oncoproteins and tumor suppressors antagonistically converge on critical nodes governing neoplastic growth, invasion, and metastasis. We discovered that phosphorylation of the ETS1 and ETS2 transcriptional oncoproteins at specific serine or threonine residues creates binding sites for the COP1 tumor suppressor protein, which is an ubiquitin ligase component, leading to their destruction. In the case of ETS1, however, phosphorylation of a neighboring tyrosine residue by Src family kinases disrupts COP1 binding, thereby stabilizing ETS1. Src-dependent accumulation of ETS1 in breast cancer cells promotes anchorage-independent growth in vitro and tumor growth in vivo. These findings expand the list of potential COP1 substrates to include proteins whose COP1-binding sites are subject to regulatory phosphorylation and provide insights into transformation by Src family kinases.
癌蛋白和肿瘤抑制因子拮抗作用于控制肿瘤生长、侵袭和转移的关键节点。我们发现,ETS1 和 ETS2 转录癌蛋白在特定丝氨酸或苏氨酸残基上的磷酸化会产生 COP1 肿瘤抑制蛋白的结合位点,COP1 是一种泛素连接酶成分,导致其降解。然而,在 ETS1 的情况下,Src 家族激酶对其邻近酪氨酸残基的磷酸化会破坏 COP1 的结合,从而稳定 ETS1。Src 依赖性的 ETS1 在乳腺癌细胞中的积累促进了体外无锚定生长和体内肿瘤生长。这些发现扩展了潜在的 COP1 底物列表,包括其 COP1 结合位点受到调节性磷酸化的蛋白质,并深入了解 Src 家族激酶的转化。